CELLESCE LIMITED

Active Cardiff

Research and experimental development on biotechnology

12 employees website.com
Research and experimental development on biotechnology
C

CELLESCE LIMITED

Research and experimental development on biotechnology

Founded 12 Apr 2013 Active Cardiff, Wales 12 employees website.com
Research and experimental development on biotechnology

Previous Company Names

BBF BIO LIMITED 12 Apr 2013 — 29 Oct 2013
Accounts Due 30 Jun 2026 1 month remaining
Confirmation Submitted 15 Apr 2026 Next due 26 Apr 2027 11 months remaining
Net assets £847K £6M 2024 year on year
Total assets £938K £250K 2024 year on year
Total Liabilities £91K £6M 2024 year on year
Charges 2
2 satisfied

Contact & Details

Contact

Registered Address

1 Longwood Drive Cardiff CF14 7HY Wales

Telephone

0800 000 0000

Website

www.example.com

Full company profile for CELLESCE LIMITED (08484947), an active company based in Cardiff, Wales. Incorporated 12 Apr 2013. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Balance Sheet & P&L (2014–2024)

Cash in Bank

N/A

Decreased by £23.38k (-100%)

Net Assets

£846.69k

Increased by £5.58M (+118%)

Total Liabilities

£91.23k

Decreased by £5.83M (-98%)

Turnover

£367.31k

Increased by £104.02k (+40%)

Employees

12

Debt Ratio

10%

Decreased by 488 (-98%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2022
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 3
Grants 7

Investors (5)

Investor NameInvestor SinceParticipating Rounds
Investor 1Apr 2017Unknown/Other, Seed
Investor 2Mar 2018Seed
Investor 3Mar 2018Seed

Share Capital

Share Capital

Share allotments and capital structure

32 Allotments 7,880 Shares £1.97m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
5 Dec 20222,500£25£25
6 Jun 2020101£6k£60.051
14 Nov 20191,850£111k£60.05
28 Jun 201933£20k£600.51
28 May 20191,831£1.10m£600.51

Officers

Officers

2 active 1 resigned
Status
Battle, Jaison MahometDirectorAmericanUnited States475 Dec 2022Active
Summers, Nicola AnnDirectorBritishEngland5612 Nov 2025Active

Shareholders

Shareholders (49)

Molecular Devices (uk) Limited
100.0%
89,701
Dr Paul Jenkins
0.0%
0

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Active
Notified 5 Dec 2022
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

CELLESCE LIMITED Current Company

Charges

Charges

2 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
15 Apr 2026Confirmation StatementConfirmation statement made on 12 Apr 2026 with no updates
2 Apr 2026CapitalCapital Statement Capital Company With Date Currency Figure
2 Apr 2026CapitalCapital Statement Capital Company With Date Currency Figure
16 Mar 2026CapitalStatement by Directors
16 Mar 2026ResolutionResolutions
15 Apr 2026 Confirmation Statement

Confirmation statement made on 12 Apr 2026 with no updates

2 Apr 2026 Capital

Capital Statement Capital Company With Date Currency Figure

2 Apr 2026 Capital

Capital Statement Capital Company With Date Currency Figure

16 Mar 2026 Capital

Statement by Directors

16 Mar 2026 Resolution

Resolutions

Recent Activity

Latest Activity

Confirmation statement made on 12 Apr 2026 with no updates

2 weeks ago on 15 Apr 2026

Capital Statement Capital Company With Date Currency Figure

1 months ago on 2 Apr 2026

Capital Statement Capital Company With Date Currency Figure

1 months ago on 2 Apr 2026

Statement by Directors

1 months ago on 16 Mar 2026

Resolutions

1 months ago on 16 Mar 2026